@article{Philippe Moreau_Halyna Pylypenko_Sebastian Grosicki_Ievgenii Karamanesht_Xavier Leleu_Grigoriy Rekhtman_Zvenyslava Masliak_Pawel Robak_Dixie-Lee Esseltine_Huaibao Feng_William Deraedt_Helgi van de Velde_Bertrand Arnulf_2015, place={Pavia, Italy}, title={Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study}, volume={100}, url={https://haematologica.org/article/view/7393}, DOI={10.3324/haematol.2014.118182}, number={5}, journal={Haematologica}, author={Philippe Moreau and Halyna Pylypenko and Sebastian Grosicki and Ievgenii Karamanesht and Xavier Leleu and Grigoriy Rekhtman and Zvenyslava Masliak and Pawel Robak and Dixie-Lee Esseltine and Huaibao Feng and William Deraedt and Helgi van de Velde and Bertrand Arnulf}, year={2015}, month={May}, pages={e207-e210} }